inovio stock Archives

Bets on Tech Stocks and Cryptocurrencies Brought Small Fortune to US Top Funds in 2020

Meanwhile, funds that trusted oil and gas, suffered losses. In particular, the Direxion Daily S&P Oil&Gas E&P 2X ETF lost 97.3% this year. The Direxion Daily Junior Gold Miners Bear 2X ETF plunged 95.5% in 2020.

Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday

Business News, Market News, News, Stocks, Story of the Day

By Darya Rudz Jun 26, 2020

The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage.

Inovio (INO) Stock Up 2% in Pre-Market, Jim Cramer Shares His Thoughts on It

Business News, Editor's Choice, Market News, News, Stocks

By Darya Rudz May 18, 2020

In the last three months, INO has pulled in more than 181% returns. For 2020, Inovio (INO) investors have seen 233.33% returns.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Rose 8% Yesterday, Up 5% Now as Hunt for COVID-19 Vaccine Goes On

By Teuta Franjkovic May 13, 2020

Inovio (INO) stock was jumped 8% yesterday, is in the green now after the company released its fiscal Q1 earnings report, while it is working on a coronavirus vaccine.

Business News, Editor's Choice, Market News, News, Stocks

Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews

By Tolu Ajiboye May 6, 2020

Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Rises 5.40% Today after 14.55% Loss on Friday

By Tolu Ajiboye May 4, 2020

While the company has had great gains as it works on a COVID-19 vaccine, Inovio (INO) stock fell last Friday, was down in the-premarket today but is up as trading began.

Business News, Editor's Choice, Market News, News, Stocks

INO Stock Up 4% Now, Inovio to Recruit All Coronavirus Vaccine Volunteers by End of April

By Darya Rudz Apr 24, 2020

Thanks to the progress in the vaccine development, Inovio (INO) stock has given a boost to investor confidence. Since the end of 2019, Inovio shares are 264,55% up. In the last month alone, the rise is 65%.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Rose 9.5% Yesterday, Up 4% in Pre-market as Vaccine Space Gets on Fire

By Steve Muchoki Apr 21, 2020

As of the market closed on Monday, shares of Inovio Pharmaceuticals (INO) were up by 9.6%, while Moderna (MRNA) rose 10.3%. Novavax (NVAX) blasted higher by 24.7%, and VBI Vaccines (VBIV) posted a comparable 24.2% gain.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Down 4% on Monday, 1% Today, Can It Be Multimillionaire-maker Stock?

By Andy Watson Apr 14, 2020

Inovio Pharmaceuticals alongside Moderna are edging close to providing a vaccine for the novel coronavirus. However, Inovio (INO) stock is down these days.

Business News, Indices, Market News, News, Stocks

Inovio (INO) Stock Plunges 28% in Pre-Market Results Today Following Disappointing Q4 Report

By Tolu Ajiboye Mar 13, 2020

Inovio stock has been swung significantly in the last 24 hours after rising on news of a new grant and plunging on news of its poor Q4 report.

Business News, Editor's Choice, Market News, News, Stocks

Why Inovio Pharmaceuticals (INO) Stock Is Top Performer among Coronavirus Vaccine Stocks

By Tolu Ajiboye Mar 9, 2020

At the moment, Inovio (INO) is probably the best performing stock among the biotech companies, with over 300% gains. Let’s take a look at the reasons why this is so.